At the news
? NEUTRALIMPACT 2/10 PRESS-RELEASE filed May 20, 2026 at 17:30 ET
Dyne Therapeutics granted inducement equity awards to 17 newly hired employees, consisting of stock options for 296,500 shares and RSUs for 94,100 shares, vesting over four years. This is a routine compensation action with no material financial impact.
- Inducement grants to 17 new employees.
- Stock options for 296,500 shares at closing price.
- RSUs for 94,100 shares.
- Both award types vest over four years.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access